The effects of drugs of abuse on clock genes

Drug News and Perspectives

Volumn 21, Issue 4, 2008, Pages 211-217

  Perreau Lenz, Stéphanie ^a   Spanagel, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; MELATONIN; MESSENGER RNA; METHADONE; METHAMPHETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

ALCOHOLISM; ANALGESIC ACTIVITY; BIOLOGICAL RHYTHM; BRAIN REGION; CIRCADIAN RHYTHM; COCAINE DEPENDENCE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR CLOCK; MORPHINE ADDICTION; NONHUMAN; PATHOGENESIS; PLACE PREFERENCE; REINFORCEMENT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; CELL CYCLE PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; ETHANOL; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; STREET DRUGS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 49349096243     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.4.1213350     Document Type: Review

References (86)

1. Aschoff, J. and Wever, R. Spontanperiodik des menschen bei ausschluss aller zeitgeber. Naturwissenschaften 1962, 49: 337-42.
2. Lenox, R.H. and Frazier, T.W. Methadone induced mortality as afunction of the circathan cycle. Nature 1972, 239(5372): 397-8.
3. Sinnett, E.R. and Morris, J.B. Temporal patterns of the use of non-prescribed drugs. Percept Mot Skills 1977, 45(3 Pt. 2): 1239-45.
4. Argyle, E. Circadian variation of the lethality of methadone. Nature 1973, 242(5396): 332.
5. Remberg, A. et al. Variations circadiennes des effets de l'ethanol el de l'ethanolamie chez l'homme adulte sain. Etude chronopharmacologique. J Physiol 1975, 70: 435-56.
6. Raymond, R.C., Warren, M., Morris, R.W. and Leikin, J.B. Periodicity of presentations of drugs of abuse and overdose in an emergency department. J Toxicol Clin Toxicol 1992, 30(3): 467-78.
7. Erickson, T.B., Lee, J., Zautcke, J.L. and Morris, R. Analysis of cocaine chronotoxicology in an urban ED. Am J Emerg Med 1998, 16(6): 568-71.
8. Gaytan, O., Swann, A. and Dafny, N. Diurnal differences in rat's motor response to amphetamine. Eur J Pharmacol 1998, 345(2): 119-28.
9. Yoshida, M., Ohdo, S., Takane, H., Tomiyoshi, Y., Matsuo, A., Yukawa, E. and Higuchi, S. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice. J Pharmacol Exp Ther 2003, 305(3): 1200-5.
10. Perreau-Lenz, S., Pévet, P., Buijs, R.M. and Kalsbeek, A. The biological clock: the bodyguard of temporal homeostasis. Chronobiol Int 2004, 21(1): 1-25.
11. Yoo, S.H., Yamzaki, S., Lowrey, P.L. et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci U S A 2004, 101(15): 5339-46.
12. Gachon, F., Nagoshi, E., Browns, S.A., Ripperquer, J. and Schibler, U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004, 113(3): 103-12.
13. Albrecht, U. and Eichele, G. The mammalian circadian clock. Curr Opin Genet Dev 2003, 13(3): 271-7.
14. Ko, C.H. and Takahashi, J.S. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006, 15 Spec No 2, R271-7.
15. Delaunay, F. and Laudet, V. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet 2002, 18(12): 595-7.
16. Masubuchi, S., Honma, S., Abe, H., Ishizaki, K., Namihira, M., Ikeda, M. and Honma, K. Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats. Eur J Neurosci 2000, 12(12): 4206-14.
17. Nikaido, T., Akiyama, M., Moriya, T. and Shibata, S. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine. Mol Pharmacol 2001, 59(4): 894-900.
18. Iijima, M., Nikaido, T., Akiyama, M., Moriya, T. and Shibata, S. Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur J Neurosci 2002, 16(5): 921-9.
19. Yuferov, V., Kroslak, T., Laforqe, K.S., Zhou, Y., Ho, A. and Kreek, M.J. Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis. Synapse 2003, 48(4): 157-69.
20. Uz, T., Ahmed, R., Akhisaroqlu, M., Kurtuncu, M., Imbesi, M., Dirim Arslan, A. and Manev, H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 2005, 134(4): 1309-16.
21. Shang, E.H. and Zhdanova, I.V. The circadian system is a target and modulator of prenatal cocaine effects. PLoS ONE 2007, 2, e587.
22. Sanchis-Segura, C. and Spanagel, R. Behavioural assessment of drug reinforcement and addictive features in rodents: An overview. Addict Biol 11:2-38.
23. Tzschentke, T. Measuring reward with the conditioned place preference (conditioned place preference) paradigm: Update of the last decade. Addict Biol 12: 227-462.
24. Andretic, R., Chaney, S. and Hirsch, J. Requirement of circadian genes for cocaine sensitization in Drosophila. Science 1999, 285(5430): 1066-8.
25. Zheng, B., Albrecht, U., Kaasik, K. et al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001, 105(5): 683-94.
26. Zheng, B., Larkin, D.W., Albrecht, U. et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 1999, 400(6740): 169-73.
27. Abarca, C., Albrecht, U. and Spanagel, R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Nad Acad Sci U S A 2002, 99(13): 9026-30.
28. Uz, T., Javaid, J.I. and Manev, H. Circadian differences in behavioral sensitization to cocaine: putative role of arylalkylamine N-acetyltransferase. Life Sci 2002, 70(25): 3069-75.
29. Uz, T., Akhisaroglu, M., Ahmed, R. and Manev, H. The pineal gland is critical for cireadian period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology 2003, 28(12): 2117-23.
30. Kurtuncu, M., Arslan, A.D., Akbisaroglu, M., Manev, H. and Uz, T. Involvement of the pineal gland in diurnal cocaine reward in mice. Eur J Pharmacol 2004, 489(3): 203-5.
31. Akhisaroglu, M., Ahmed, R., Kurtunku, M., Manev, H. and Uz, T. Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species. Pharmacol Biochem Behav 2004, 79(1): 37-42.
32. McClung, C.A., Sidiropoulou, K., Vitatema, M., Takahashi, J.S., White, F.J., Cooper, D.C. and Nestler, E.J. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A 2005, 102(26): 9377-81.
33. Spanagel, R. and Weiss, F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999, 22(11): 521-7.
34. Vanderschuren, L.J. and Kalivas, P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151(2-3): 99-120.
35. Cornish, J.L. and Kalivas, P.W. Cocaine sensitization and craving: differing roles for dopamine and glulamate in the nucleus accumbens. J Addict Dis 2001, 20(3): 43-54.
36. Castañeda, T.R., de Prado, B.M., Prieto, D. and Mora, F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 2004, 36(3): 177-85.
37. Andretic, R. and Hirsh, J. Circadian modulation of dopamine receptor responsiveness in Drosophila melanogaster. Proc Natl Acad Sci U S A 2000, 97(4): 1873-8.
38. Hiller- Sturmhofel, S. and Kulkosky, P. Chronobiological regulation of alcohol intake. Alcohol Res Health 2001, 25(2): 141-8.
39. Freund, G. Alcohol consumption and its circadian distribution in mice. J Nutr 1970, 100(1): 30-6.
40. Jelic, P., Shih, M.F. and Taberner, P.V. Diurnal va-riation in plasma ethanol levels of TO and CBA mice on chronic ethanol drinking or ethanol liquid diet schedules. Psychopharmacology (Berl) 1998, 138(2), 143-50.
41. Lagerspetz, K.Y. Diurnal variation in the effects of alcohol and in the brain 5-hydroxytryptamine metabolism in mice. Acta Pharmacol Toxicol (Copenh) 1972, 31: 509-20.
42. Deimling, M.J. and Schnell, R.C. Circadian rhythms in the biological response and disposition of ethanol in the mouse. J Pharmacol Exp Ther 1980, 213(1): 1-8.
43. Baird, T.J., Briscoe, R.J., Vallett, M., Vanecek, S.A., Holloway, F.A. and Gauvin, D.V. Phase-response curve for ethanol: alterations in circadian rhythms of temperature and activity in rats. Pharmacol Biochem Behav 1998, 61(3): 303-15.
44. Sato, Y, Seo, N. and Kobahashi, E. The dosing-time dependent effects of intravenous hypnotics in mice. Anesth Analg 2005, 101(6): 1706-8.
45. Jones, B.M. and Paredes, A. Circadian variation of ethanol metabolism in alcoholics. Br J Addict Alcohol Other Drugs 1974, 69(1): 3-10.
46. Sturtevant, F.M. Chronopharmacokinetics of ethanol. I. Review of the literature and theoretical considerations. Chronobiologia 1976, 3(3): 237-62.
47. Minors, D.S. and Waterhouse, J.M. Aspects of chronopharmacokinetics and chronergy, of ethanol in healthy man. Chronobiologia 1980, 7(4): 465-80.
48. Yap, M., Mascord, D.J., Starmer, J.A. and Whitfield, J.B. Studies on the chronopharmacology of ethanol. Alcohol Alcohol 1993, 28(1): 17-24.
49. Lötterle, J., Husslein, E.M., Bolt, J. and Wirtz, P.M. Diurnal differences in alcohol absorption. Blutalkohol 1998, 26(6): 369-75.
50. Danel, T. and Touitou, Y. Chronobiology of alcohol: From chronokinetics to alcohol-related alterations of the circadian system. Chronobiol Int 2004, 21(6): 923-35.
51. Kakihana, R. and Moore, J.A. Circadian rhythm of corticosterone in mice: the effect of chronic consumption of alcohol. Psychopharmacologia 1976, 46(3): 301-5.
52. Rosenwasser, A.M. Alcohol, antidepressants, and circadian rhythms. Human and animal models. Alcohol Res Health 2001, 25(2): 126-35.
53. Danel, T., Libersa, C. and Touitou, Y. The effect of alcohol consumption on the circadian control of human core body temperature is time dependent. Am J Physiol Regul Integr Comp Physiol 2001, 281(1): R52-5.
54. Roehrs, T. and Roth, T. Sleep, sleepiness, and alcohol use. Alcohol Res Health 2001, 25(2): 101-9.
55. Chen, C.P., Kuhn, P., Advis, J.P. and Sarkar, D.K. Chronic ethanol consumption impairs the circadian rhythm of pro-opiome-lanocortin and period genes mRNA expression in the hypothalamus of the male rat. J Neurochem 2004, 88(6): 1547-54.
56. Chen, C.P., Kuhn, P., Advis, J.P. and Sarkar, D.K. Prenatal ethanol exposure alters the expression of period genes governing the circadian function of beta-endorphin neurons in the hypothalamus. J Neurochem 2006, 97(4): 1026-33.
57. Zghoul, T, Abarca, C., Sanchis-Segura, C., Albrecht U., Schumann, G and Spanagel, R. Ethanol self-administration and reinstatement of ethanol-seeking behavior in Per1(Brdm1) mutant mice. Psychopharmacology (Berl) 2007, 190(1): 13-9.
58. Spanagel, R., Pendyala, G., Abarca, C. et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 2005, 11(1): 35-42.
59. Tsai, G. and Coyle, J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 1998, 49: 173-84.
60. Pulvirenti, L. and Diana, M. Drug depedence as a disorder of neural plasticity: focus on dopamine and glutamate. Rev Neurosci 2001, 12(2): 141-58.
61. Siggins, G.R., Martin GL, Roberto, M. and Nie, Z., Madamba, S., De Lcea, L. Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 2003, 1003, 196-211.
62. Heinz, A. et al. Neurobiological correlates of the disposition and maintenance of alcoholism. Pharmacopsychiatry 2003, 36 (Suppl 3): S255-258.
63. Gass, J.T. and Olive, M.F. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 2008, 75(1): 218-65.
64. Krystal, J.H., Petrakis, I.L., Mason, G., Trevisan, L. and D'Souza, D.C. N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 2003, 99(1): 79-94.
65. Spanagel, R. and Zieglgansberger, W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997, 18(2): 54-9.
66. Dahchour, A. and De Witte, P. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res 2003, 27(3): 465-70.
67. Schumann, G. Okey Lecture 2006: identifying the neurobiological mechanisms of addictive behavior. Addiction 2007, 102(11): 1689-95.
68. Morris, R.W. and Lutsch, E.F. Susceptibility to morphine-induced analgesia in mice. Nature 1967, 216(5114): 494-5.
69. Oliverio, A. et al. Opiate analgesia: evidence for circadian rhythms in mice. Brain Res 1982, 249(2): 265-70.
70. Bornschein, R.L., Crokett, R.S., and Smith, R.P. Diurnal variations in the analgesic effectiveness of morphine in mice. Pharmacol Biochem Behav 1977, 6(6): 621-6.
71. Ayhan, I.H. Daily susceptibility variations to the morphine-induced hyperactivity of rats. J Pharm Pharmacol 1974, 26(1): 76-8.
72. Naber, D., Wirz-Justice, A. and Kafka, M.S. Circadian rhythm in rat brain opiate receptor. Neurosci Lett 1981, 21(1): 45-50.
73. Oyefeso, A., Sedqwick, P. and Ghodse, H. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend 1997, 48(1): 9-16.
74. Stinus, L., Robert, C., Karasinski, P. and Limoge, A. Continuous quantitative monitoring of spontaneous opiate withdrawal: locomotor activity and sleep disorders. Pharmacol Biochem Behav 1998, 59(1): 83-9.
75. Caillé, S., Stinus, L., Espejo, E.F., De Deurwaerdère, P., Spinato, U. and Koob, G.F. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats. Neuropsychopharmacology 2003, 28(2): 276-83.
76. Cutler, D.J., Mundey, M.K. and Mason, R. Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro. Brain Res Bull 1999, 50(2): 119-25.
77. Ammon, S., Mayer, P., Riechert, U., Tischmeyer, H. and Höllt, V. Microarray analysis of genes expressed in the frontal cortex ofrats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res Mol Brain Res 2003, 112(1-2): 113-25.
78. Ammon-Treiber, S. and Höllt, V. Morphine-induced changes of gene expression in the brain. Addict Biol 2005, 10(1): 81-89.
79. Wang, X.W., Xin, Y., Liu, H. et al. Altered expression of circadian clock gene, mPer1, in mouse brain and kidney under morphine dependence and withdrawal. J Circadian Rhythms 2006, 4: 9.
80. Liu, Y., Wang Y., Wan, C. et al. The role of mPer1 in morphine dependence in mice. Neuroscience 2005, 130(2): 383-8.
81. Liu, Y., Wang, Y., Ziang, Z., Wan, C., Zhou, W. and Wang, Z. The extracellular signal-regulated kinase signaling pathway is involved in the modulation of morphine-induced reward by mPer1. Neuroscience 2007, 146(1): 265-71.
82. Perreau-Lenz, S. et al. Differential involvement of mPer1 and mPer2 genes in the development of morphine-induced tolerance and withdrawal. Behav Pharmacol 2007, 18(Suppl. 1): S80.
83. Perreau-Lenz, S. et al. Clock genes running amok. Clock genes and their role in drug addiction and depression. EMBO Rep 2007, 8: 20-4.
84. Malison, R.T., Kranzler, R.H., Yang, B.Z. and Galernter, J. Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet 2006, 16(6): 245-9.
85. Hong, H.K., Chong, J.L., Song, W. et al. Inducible and reversible Clock gene expression in brain using the tTA system for the study of circadian behavior. PLoS Genet 2007, 3(2): e33.
86. McDearmon, E.L., Patel, K.L., Ko, C.H. et al. Dissecting the functions of the mammalian clockprotein BMAL1 by tissue-specific rescue in mice. Science 2006, 314(5803): 1304-8.